Trial intelligence / Profile preview

Effect of Methylnaltrexone on GI Transit in Healthy Volunteers

NCT01055704Phase 4Completed

Sponsor
Mayo Clinic
Start
Nov 2009
Primary completion
Feb 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of methylnaltrexone in opioid-induced constipation (OIC), sponsored by Mayo Clinic. Started Nov 2009; status: completed.

02

Drugs

methylnaltrexone
03

Conditions

opioid-induced constipation (OIC)

Beyond the preview

Go deeper on NCT01055704.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01055704.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call